Gary Eichenbaum
Papers
1
Total Citations
35
H-Index
1
About
Gary Eichenbaum is a pharmaceutical scientist whose work centers on enhancing the bioavailability of poorly water-soluble compounds—a critical bottleneck in drug development. His major contribution lies in pioneering a parallel screening approach that uses only milligram quantities of material to identify solubility-enhancing formulations, dramatically accelerating early-stage drug discovery while conserving precious active pharmaceutical ingredients. This methodology, detailed in his most-cited 2006 paper (35 citations), provides a systematic, high-throughput strategy for selecting optimal formulation strategies, bridging the gap between preclinical candidate identification and in vivo efficacy. Eichenbaum’s impact is evident in how his framework has been adopted by pharmaceutical researchers to streamline formulation development, reducing time and cost in bringing new therapies to patients. His work exemplifies the intersection of practical problem-solving and rigorous science, offering a template for tackling solubility challenges that plague many promising drug candidates. For students and researchers, Eichenbaum’s approach underscores the value of creative, resource-efficient experimentation in overcoming fundamental barriers to drug delivery.
Research Focus
Key Achievements
Top Papers
- 1